765 related articles for article (PubMed ID: 10685741)
1. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
3. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
4. Treat or investigate?
Galmiche JP
Eur J Gastroenterol Hepatol; 1999 Jun; 11 Suppl 1():S11-5. PubMed ID: 10443907
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological management of gastroesophageal reflux disease.
Lowe RC; Wolfe MM
Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD.
Miller SM; Goldstein JL; Gerson LB
Am J Gastroenterol; 2011 Aug; 106(8):1439-45. PubMed ID: 21448144
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
Habu Y; Oyasu K; Wakamatsu T; Sumitomo Y; Kiyota K; Inokuchi H; Kawai K
Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
[TBL] [Abstract][Full Text] [Related]
8. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
9. Management strategies for gastroesophageal reflux disease.
Bak YT
J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
[TBL] [Abstract][Full Text] [Related]
10. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
[TBL] [Abstract][Full Text] [Related]
12. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
Arguedas MR; Heudebert GR; Klapow JC; Centor RM; Eloubeidi MA; Wilcox CM; Spechler SJ;
Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
[TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness analysis for the treatment of non-erosive reflux disease].
Habu Y; Fukui Y; Maruno T; Hisatsune H; Kawai K
Nihon Rinsho; 2007 May; 65(5):951-5. PubMed ID: 17511239
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches to reflux disease, focusing on acid secretion.
Kinoshita Y; Adachi K; Fujishiro H
J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
[TBL] [Abstract][Full Text] [Related]
15. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
Chan J; Hui RL; Szpakowski JL
Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
[TBL] [Abstract][Full Text] [Related]
16. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
Noar MD; Lotfi-Emran S
Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
[TBL] [Abstract][Full Text] [Related]
17. "Refractory GERD": acid, nonacid, or not GERD?
Vaezi MF
Am J Gastroenterol; 2004 Jun; 99(6):989-90. PubMed ID: 15180714
[TBL] [Abstract][Full Text] [Related]
18. Management of gastroesophageal reflux disease.
Heidelbaugh JJ; Nostrant TT; Kim C; Van Harrison R
Am Fam Physician; 2003 Oct; 68(7):1311-8. PubMed ID: 14567485
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy of gastroesophageal reflux disease in secondary and tertiary care settings.
Tytgat GN
Yale J Biol Med; 1999; 72(2-3):219-26. PubMed ID: 10780584
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
